We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » On Procedural Grounds, FDA Denies Citizen Petition to Look Into Data Tampering at Cassava Sciences
On Procedural Grounds, FDA Denies Citizen Petition to Look Into Data Tampering at Cassava Sciences
Amid accusations of manipulating data associated with trials for its Alzheimer’s drug candidate simufilam, Cassava Sciences had a bit of good news when the FDA denied a citizen petition pressing the agency to investigate claims that Cassava changed trial data.